Protagenic Therapeutics, Inc.\new Accumulated Other Comprehensive Income
Protagenic Therapeutics, Inc.\new (PTIX) had Accumulated Other Comprehensive Income of -$129.86 thousand as of 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent › Accumulated Other Comprehensive Income (Loss), Net of Tax
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2025-05-13
- 2025-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$129.86K.
- 2024-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$129.85K.
- 2024-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$130.25K.
- 2024-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$130.16K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2025-03-31 | -$129.86K 10-Q · filed 2025-05-13 |
| 2024-12-31 | -$129.85K 10-Q · filed 2025-05-13 |
| 2024-09-30 | -$130.25K 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$130.16K 10-Q · filed 2024-08-14 |
| 2024-03-31 | -$86.77K 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$113.55K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$617.74K 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$586.46K 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$628.76K 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$676.91K 10-K/A · filed 2024-05-14 |
| 2022-09-30 | -$615.11K 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$449.68K 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$399.36K 10-Q · filed 2022-05-13 |
| 2021-12-31 | -$248.35K 10-K · filed 2023-03-31 |
| 2021-09-30 | -$172.38K 10-Q · filed 2021-11-15 |
| 2021-06-30 | -$170.61K 10-Q · filed 2021-08-16 |
| 2021-03-31 | -$171.09K 10-Q · filed 2021-05-17 |
| 2020-12-31 | -$171.59K 10-K · filed 2022-04-07 |
| 2020-09-30 | -$172.96K 10-Q · filed 2020-11-16 |
| 2020-06-30 | -$173.70K 10-Q · filed 2020-08-14 |
| 2020-03-31 | -$174.78K 10-Q · filed 2020-06-18 |
| 2019-12-31 | -$172.36K 10-K · filed 2021-03-25 |
| 2019-09-30 | -$173.12K 10-Q · filed 2019-11-14 |
| 2019-06-30 | -$173.09K 10-Q · filed 2019-08-14 |
| 2019-03-31 | -$173.39K 10-Q · filed 2019-05-16 |
| 2018-12-31 | -$170.54K 10-K · filed 2020-04-29 |
| 2018-09-30 | -$165.15K 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$164.66K 10-Q · filed 2018-08-14 |
| 2018-03-31 | -$168.71K 10-Q · filed 2018-05-15 |
| 2017-12-31 | -$167.81K 10-K · filed 2019-03-29 |
| 2017-09-30 | -$166.84K 10-Q · filed 2017-11-13 |
| 2017-06-30 | -$173.85K 10-Q · filed 2017-08-08 |
| 2017-03-31 | -$179.60K 10-Q · filed 2017-05-15 |
| 2016-12-31 | -$181.63K 10-K · filed 2018-04-02 |
| 2016-09-30 | -$174.11K 10-Q · filed 2016-11-17 |
| 2016-06-30 | -$170.94K 10-Q · filed 2016-08-15 |
| 2016-03-31 | -$148.23K 10-Q · filed 2016-07-25 |
| 2015-12-31 | -$148.65K 10-K/A · filed 2017-05-08 |
| 2014-12-31 | -$147.58K 8-K/A · filed 2016-07-12 |
| 2011-09-30 | $32.00K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $80.00K 10-Q/A · filed 2011-09-07 |
| 2010-12-31 | $42.00K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |